JBM (Healthcare) Limited (2161.HK)
HKD 2.23
(0.9%)
HKD 2.23
(0.9%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.38 Billion HKD | -1.03% |
| 2022 | 1.4 Billion HKD | 5.3% |
| 2021 | 1.33 Billion HKD | -3.53% |
| 2020 | 1.38 Billion HKD | 0.95% |
| 2019 | 1.36 Billion HKD | 5.85% |
| 2018 | 1.29 Billion HKD | 14.83% |
| 2017 | 1.12 Billion HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 1.38 Billion HKD | -1.03% |
| 2023 Q2 | 1.43 Billion HKD | 0.0% |
| 2023 Q4 | 1.38 Billion HKD | 0.0% |
| 2022 Q4 | 1.4 Billion HKD | 0.0% |
| 2022 FY | 1.4 Billion HKD | 5.3% |
| 2022 Q2 | 1.33 Billion HKD | 0.0% |
| 2021 Q2 | 1.34 Billion HKD | 0.0% |
| 2021 FY | 1.33 Billion HKD | -3.53% |
| 2021 Q4 | 1.33 Billion HKD | 0.0% |
| 2020 Q2 | - HKD | -100.0% |
| 2020 Q4 | 1.38 Billion HKD | 0.0% |
| 2020 Q1 | 1.42 Billion HKD | 0.0% |
| 2020 FY | 1.38 Billion HKD | 0.95% |
| 2019 FY | 1.36 Billion HKD | 5.85% |
| 2018 FY | 1.29 Billion HKD | 14.83% |
| 2017 FY | 1.12 Billion HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -53.03% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 93.832% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -7.886% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | 33.717% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -190.451% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | 51.959% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | 50.887% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | 19.605% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -64.545% |
| SSY Group Limited | 11.96 Billion HKD | 88.395% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 60.173% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 99.489% |